A clinical comparison of sumatriptan nasal spray and dihydroergotamine nasal spray in the acute treatment of migraine

International Journal of Clinical Practice

Volumn 54, Issue 5, 2000, Pages

  Boureau, François ^a   Kappos, L ^b   Schoenen, J ^b   Esperanca, P ^b   Ashford, E ^b  

^a Centre de Traitement de la Douleur   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMIGRAINE AGENT; DIHYDROERGOTAMINE; SUMATRIPTAN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MULTICENTER STUDY; NAUSEA; NOSE DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TASTE DISORDER; VOMITING;

ADULT; AGED; BELGIUM; CROSS-OVER STUDIES; DIHYDROERGOTAMINE; DOUBLE-BLIND METHOD; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PORTUGAL; SUMATRIPTAN; SWITZERLAND; VASOCONSTRICTOR AGENTS;

EID: 17144474717     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Tansey MJB, Pilgrim AJ, Lloyd K. Sumatriptan in the acute treatment of migraine. J Neurol Sci 1993; 114: 109-116.
2. The Subcutaneous Sumatriptan International Study Group. Treatment of migraine attacks with sumatriptan. N Engl J Med 1991; 325: 316-321.
3. The Oral Sumatriptan Dose-defining Study Group. Sumatriptan: an oral dose-defining study. Eur Neurol 1991; 31: 300-305.
4. The Finnish Sumatriptan Group and the Cardiovascular Clinical Research Group. A placebo-controlled study of intranasal sumatriptan for the acute treatment of migraine. Eur Neurol 1991; 31: 332-338.
5. Ryan R, Elkind A, Baker CC et al. Sumatriptan nasal spray for the acute treatment of migraine: results of two clinical studies. Neurology 1997; 49: 1225-1230.
6. Bousser MG, Lorai Y. Efficacy of dihydroergotamine nasal spray in the acute treatment of migraine attacks. Cephalalgia 1985; 5(suppl 3): 554-555.
7. Di Serio F, Patin J, Freidman A. USA trials of dihydroergotamine nasal spray in the acute treatment of migraine headache. Cephalalgia 1989; 9(suppl 10): 344-345.
8. Krause KH, Bleicher MA. Dihydroergotamine nasal spray in the treatment of migraine attacks. Cephalalgia 1985; 5(suppl 3): 138-139.
9. Massiou H. Dihydroergotamine nasal spray in prevention and treatment of migraine attacks: two controlled trials versus placebo. Cephalalgia 1987; 7(suppl 6): 440-441.
10. Paiva T, Esperanca P, Marcelino L, Assis G. A double-blind trial with dihydroergotamine spray in migraine crisis. Cephalalgia 1985; 5(suppl 3): 140-141.
11. Rohr J, Dufresne JJ. Dihydroergotamine nasal spray for the treatment of migraine attacks: a comparative double-blind crossover study with placebo. Cephalalgia 1985; 5(suppl 3): 142-143.
12. Tulunay FC, Karan O, Aydin N et al. Dihydroergotamine nasal spray during migraine attacks: a double-blind crossover study with placebo. Cephalalgia 1987; 7: 131-133.
13. Ziegler D, Ford R, Kriegler J et al. Dihydroergotamine nasal spray for the acute treatment of migraine. Neurology 1994; 44: 447-453.
14. Touchon J, Bertin L, Pilgrim AJ et al. A comparison of subcutaneous sumatriptan and dihydroergotamine nasal spray in the acute treatment of migraine. Neurology 1996; 47: 361-365.
15. Headache Classification Committee of the International Headache Society. Classification of diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8(suppl 7): 19-21.
16. Kenward MG, Jones B. A log-linear model for binary cross-over data. Appl Stats 1987; 36(2): 192-204.
17. Gart JJ. An exact test for comparing matched proportions in cross-over designs. Biometrika 1969; 56: 75-80.
18. Prescott RJ. The comparison of success rates in cross-over trials in the presence of an order effect. Appl Stats 1981; 30: 9-15.
19. Kenward MG, Jones N. Alternative approaches to the analysis of binary and categorical repeated measurements. J Biopharm Stats 1992; 2: 137-170.